keyword
https://read.qxmd.com/read/38630597/assessing-the-value-of-incorporating-a-polygenic-risk-score-with-non-genetic-factors-for-predicting-breast-cancer-diagnosis-in-the-uk-biobank
#21
JOURNAL ARTICLE
Jennifer A Collister, Xiaonan Liu, Thomas J Littlejohns, Jack Cuzick, Lei Clifton, David J Hunter
BACKGROUND: Previous studies have demonstrated that incorporating a polygenic risk score (PRS) to existing risk prediction models for breast cancer improves model fit, but to determine its clinical utility the impact on risk categorisation needs to be established. We add a PRS to two well-established models and quantify the difference in classification using the net reclassification improvement (NRI). METHODS: We analysed data from 126,490 post-menopausal women of "White British" ancestry, aged 40-69 years at baseline from the UK Biobank prospective cohort...
April 17, 2024: Cancer Epidemiology, Biomarkers & Prevention
https://read.qxmd.com/read/38630509/a-quantitative-bias-analysis-approach-to-informative-presence-bias-in-electronic-health-records
#22
JOURNAL ARTICLE
Hanxi Zhang, Amy S Clark, Rebecca A Hubbard
Accurate outcome and exposure ascertainment in electronic health record (EHR) data, referred to as EHR phenotyping, relies on the completeness and accuracy of EHR data for each individual. However, some individuals, such as those with a greater comorbidity burden, visit the health care system more frequently and thus have more complete data, compared with others. Ignoring such dependence of exposure and outcome misclassification on visit frequency can bias estimates of associations in EHR analysis. We developed a framework for describing the structure of outcome and exposure misclassification due to informative visit processes in EHR data and assessed the utility of a quantitative bias analysis approach to adjusting for bias induced by informative visit patterns...
May 1, 2024: Epidemiology
https://read.qxmd.com/read/38630334/ambient-polycyclic-aromatic-hydrocarbon-exposure-and-breast-cancer-risk-in-a-population-based-canadian-case-control-study
#23
JOURNAL ARTICLE
Patrick Hinton, Paul J Villeneuve, Elisabeth Galarneau, Kristian Larsen, Deyong Wen, Jun Meng, Verica Savic-Jovcic, Junhua Zhang, Will D King
PURPOSE: Polycyclic aromatic hydrocarbons (PAHs) represent a class of ubiquitous pollutants recognized as established human carcinogens and endocrine-disrupting chemicals. PAHs have seldom been modeled at the population-level in epidemiological studies. Fluoranthene is a prevalent PAH in urban settings and correlates with the occurrence of other PAHs. The purpose of this study was to evaluate associations between long-term residential exposure to ambient PAHs and breast cancer risk, both pre- and post-menopausal, in Canada...
April 17, 2024: Cancer Causes & Control: CCC
https://read.qxmd.com/read/38629963/maintenance-pembrolizumab-therapy-in-patients-with-metastatic-her2-negative-breast-cancer-with-prior-response-to-chemotherapy
#24
JOURNAL ARTICLE
Toshiaki Iwase, Evan N Cohen, Hui Gao, Angela Alexander, Megumi Kai, Vivian Chiv, Xiaoping Wang, Savitri Krishnamurthy, Diane Liu, Yu Shen, Kumiko Kida, Alexandre Reuben, Rachel Layman, David Ramirez, Debu Tripathy, Stacy L Moulder, Clinton Yam, Vicente Valero, Bora Lim, James M Reuben, Naoto T Ueno
PURPOSE: Accumulating toxicities hinder indefinite chemotherapy for many patients with metastatic/recurrent HER2-negative breast cancer. We conducted a phase II trial of pembrolizumab monotherapy following induction chemotherapy to determine the efficacy of maintenance immunotherapy in patients with metastatic HER2-negative inflammatory breast cancer (IBC) and non-IBC triple-negative breast cancer (TNBC) and a biomarker study. PATIENTS AND METHODS: Patients with a complete response (CR), partial response (PR), or stable disease (SD) after at least 3 cycles of chemotherapy for HER2-negative breast cancer received pembrolizumab, regardless of programmed death-ligand 1 expression...
April 17, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38629425/benzo-a-pyrene-promotes-an-epithelial-to-mesenchymal-transition-process-in-mcf10a-cells-and-mammary-tumor-growth-and-brain-metastasis-in-female-mice
#25
JOURNAL ARTICLE
Rocio Castillo-Sanchez, Alejandra Garcia-Hernandez, Pablo Torres-Alamilla, Pedro Cortes-Reynosa, Fernando Candanedo-Gonzales, Eduardo Perez Salazar
Breast cancer is the most frequent neoplasia in developed countries and the leading cause of death in women worldwide. Epithelial-to-mesenchymal transition (EMT) is a cellular process through which epithelial cells decrease or lose their epithelial characteristics and gain mesenchymal properties. EMT mediates tumor progression, because tumor cells acquire the capacity to execute the multiple steps of invasion and metastasis. Benzo[a]pyrene (B[a]P) is an environmental organic pollutant generated during the burning of fossil fuels, wood, and other organic materials...
April 17, 2024: Molecular Carcinogenesis
https://read.qxmd.com/read/38628960/follow-up-routines-matter-for-adherence-to-endocrine-therapy-in-the-adjuvant-setting-of-breast-cancer
#26
JOURNAL ARTICLE
Carolina Aurell, Alaa Haidar, Daniel Giglio
BACKGROUND: Endocrine therapy (ET) adherence leads to increased survival in breast cancer (BC). How follow-up should be done to maximize adherence is not known. OBJECTIVES: To assess adherence to ET, factors favouring adherence to ET and effects on survival in a population-based cohort of BC patients in western Sweden. DESIGN: This is a retrospective study. METHODS: We included 358 patients operated for oestrogen receptor-positive BC and recommended 5 years of ET, in Region Halland, Sweden, year 2015 to 2016...
2024: Breast Cancer: Basic and Clinical Research
https://read.qxmd.com/read/38628892/characterization-and-evaluation-of-nano-niosomes-encapsulating-docetaxel-against-human-breast-pancreatic-and-pulmonary-adenocarcinoma-cancer-cell-lines
#27
JOURNAL ARTICLE
Mohammadreza Ajdari, Aliyeh Ranjbar, Khashayar Karimian, Maryam Karimi, Hossein Heli, Naghmeh Sattarahmady
BACKGROUND: Docetaxel (DXL) is an antineoplastic agent for cancer treatment, the therapeutic efficiency of which is limited due to low solubility, hydrophobicity, and tissue specificity. OBJECTIVE: In this study, nano-niosomes were introduced for improving therapeutic index of DXL. MATERIAL AND METHODS: In this experimental study, two nano-niosomes were synthesized using Span 20® and Span 80® and a thin film hydration method with DXL loading (DXL-Span20 and DXL-Span80)...
April 2024: Journal of Biomedical Physics & Engineering
https://read.qxmd.com/read/38628888/digital-screen-time-and-the-risk-of-female-breast-cancer-a-retrospective-matched-case-control-study
#28
JOURNAL ARTICLE
Seyed Ali Reza Mortazavi, Sedigheh Tahmasebi, James C Lech, James S Welsh, Abdorasoul Taleie, Abbas Rezaianzadeh, Ali Zamani, Kanu Mega, Samaneh Nematollahi, Atefeh Zamani, Seyed Mohammad Javad Mortazavi, Lembit Sihver
BACKGROUND: As the use of electronic devices such as mobile phones, tablets, and computers continues to rise globally, concerns have been raised about their potential impact on human health. Exposure to high energy visible (HEV) blue light, emitted from digital screens, particularly the so-called artificial light at night (ALAN), has been associated with adverse health effects, ranging from disruption of circadian rhythms to cancer. Breast cancer incidence rates are also increasing worldwide...
April 2024: Journal of Biomedical Physics & Engineering
https://read.qxmd.com/read/38628818/does-the-dose-of-standard-adjuvant-chemotherapy-affect-the-triple-negative-breast-cancer-benefit-from-extended-capecitabine-metronomic-therapy-an-exploratory-analysis-of-the-sysucc-001-trial
#29
Ying Chen, Wen-Xia Li, Jia-Hua Wu, Geng-Hang Chen, Chun-Min Yang, Hai Lu, Xi Wang, Shu-Sen Wang, Heng Huang, Li Cai, Li Zhao, Rou-Jun Peng, Ying Lin, Jun Tang, Jian Zeng, Le-Hong Zhang, Yong-Li Ke, Xian-Ming Wang, Xin-Mei Liu, An-Qin Zhang, Fei Xu, Xi-Wen Bi, Jia-Jia Huang, Ji-Bin Li, Dan-Mei Pang, Cong Xue, Yan-Xia Shi, Zhen-Yu He, Huan-Xin Lin, Xin An, Wen Xia, Ye Cao, Ying Guo, Ruo-Xi Hong, Kui-Kui Jiang, Yong-Yi Zhong, Ge Zhang, Piyawan Tienchaiananda, Masahiro Oikawa, Zhong-Yu Yuan, Qian-Jun Chen
PURPOSE: Results from studies of extended capecitabine after the standard adjuvant chemotherapy in early stage triple-negative breast cancer (TNBC) were inconsistent, and only low-dose capecitabine from the SYSUCC-001 trial improved disease-free survival (DFS). Adjustment of the conventional adjuvant chemotherapy doses affect the prognosis and may affect the efficacy of subsequent treatments. This study investigated whether the survival benefit of the SYSUCC-001 trial was affected by dose adjustment of the standard adjuvant chemotherapy or not...
2024: Breast Cancer: Targets and Therapy
https://read.qxmd.com/read/38628712/identification-of-n7-methylguanosine-related-mirnas-as-potential-biomarkers-for-prognosis-and-drug-response-in-breast-cancer
#30
JOURNAL ARTICLE
Danian Dai, Hongkai Zhuang, Mao Shu, Lezi Chen, Chen Long, Hongmei Wu, Bo Chen
OBJECTIVES: The impact of N7-methylguanosine (m7G) on tumor progression and the regulatory role of microRNAs (miRNAs) in immune function significantly influence breast cancer (BC) prognosis. Investigating the interplay between m7G modification and miRNAs provides novel insights for assessing prognostics and drug responses in BC. MATERIALS AND METHODS: RNA sequences (miRNA and mRNA profiles) and clinical data for BC were acquired from the Cancer Genome Atlas (TCGA) database...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38628280/post-traumatic-growth-in-oncological-patients-during-the-covid-19-pandemic
#31
JOURNAL ARTICLE
Letizia Lafuenti, Loredana Dinapoli, Ludovica Mastrilli, Vezio Savoia, Marinella Linardos, Riccardo Masetti, Giampaolo Tortora, Vincenzo Valentini, Giovanni Scambia, Daniela P R Chieffo
BACKGROUND: Post-traumatic growth (PTG) is defined as "positive psychological change experienced as a result of the struggle with highly challenging life circumstances". Diagnosis of cancer leads to many psychological challenges. The recent pandemic forced oncological patients to face other multiple stressors. Resilience is a target of interest for PTG. The aim of this study is to analyze relationships between cancer trauma, COVID-19 pandemic stress, PTG and resilience over time. PARTICIPANTS AND PROCEDURE: One hundred forty-six patients (124 females, 22 males) in active oncological treatment were enrolled from September 2020: 45...
2024: Health Psychology Report
https://read.qxmd.com/read/38627946/diet-quality-and-cardiovascular-disease-risk-among-breast-cancer-survivors-in-the-pathways-study
#32
JOURNAL ARTICLE
Isaac J Ergas, Richard K Cheng, Janise M Roh, Lawrence H Kushi, Jacob K Kresovich, Carlos Iribarren, Mai Nguyen-Huynh, Jamal S Rana, Eileen Rillamas-Sun, Cecile A Laurent, Valerie S Lee, Charles P Quesenberry, Heather Greenlee, Marilyn L Kwan
BACKGROUND: Women with breast cancer are at higher risk of cardiovascular disease (CVD) compared with women without breast cancer. Whether higher diet quality at breast cancer diagnosis lowers this risk remains unknown. We set out to determine if higher diet quality at breast cancer diagnosis was related to lower risk of CVD and CVD-related death. METHODS: This analysis included 3415 participants from the Pathway Study, a prospective cohort of women diagnosed with invasive breast cancer at Kaiser Permanente Northern California between 2005 and 2013 and followed through December 31, 2021...
February 29, 2024: JNCI Cancer Spectrum
https://read.qxmd.com/read/38627842/ocular-metastases-profile-in-a-tertiary-hospital-in-s%C3%A3-o-paulo-brazil
#33
JOURNAL ARTICLE
Matheus Senna Pereira Ogata, Guilherme Rodrigues Ferreira, Melina Correia Morales, Arthur Gustavo Fernandes
OBJECTIVE: Ocular metastases are the most common intraocular tumours in adults. Data regarding the occurrence of these tumours in the Brazilian population is scarce. We aimed to investigate the profile of ocular metastases of patients referred to tertiary hospital service in São Paulo, Brazil. DESIGN: Retrospective study. PARTICIPANTS: Patients referred to the Ocular Oncology service of the Federal University of São Paulo with initial diagnostic hypothesis of ocular metastasis...
April 16, 2024: International Journal of Retina and Vitreous
https://read.qxmd.com/read/38627780/decoding-dynamic-mirna-cerna-interactions-unveils-therapeutic-insights-and-targets-across-predominant-cancer-landscapes
#34
JOURNAL ARTICLE
Selcen Ari Yuka, Alper Yilmaz
Competing endogenous RNAs play key roles in cellular molecular mechanisms through cross-talk in post-transcriptional interactions. Studies on ceRNA cross-talk, which is particularly dependent on the abundance of free transcripts, generally involve large- and small-scale studies involving the integration of transcriptomic data from tissues and correlation analyses. This abundance-dependent nature of ceRNA interactions suggests that tissue- and condition-specific ceRNA dynamics may fluctuate. However, there are no comprehensive studies investigating the ceRNA interactions in normal tissue, ceRNAs that are lost and/or appear in cancerous tissues or their interactions...
April 17, 2024: BioData Mining
https://read.qxmd.com/read/38627759/correlation-between-sentinel-lymph-node-biopsy-and-non-sentinel-lymph-node-metastasis-in-patients-with-cn0-breast-carcinoma-comparison-of-invasive-ductal-carcinoma-and-invasive-lobular-carcinoma
#35
JOURNAL ARTICLE
Calogero Cipolla, Simona Lupo, Nello Grassi, Giuseppe Tutino, Martina Greco, D'Agati Eleonora, Vittorio Gebbia, Maria Rosaria Valerio
BACKGROUND: Some studies have suggested that axillary lymph node dissection (ALND) can be avoided in women with cN0 breast cancer with 1-2 positive sentinel nodes (SLNs). However, these studies included only a few patients with invasive lobular carcinoma (ILC), so the validity of omitting ALDN in these patients remains controversial. This study compared the frequency of non-sentinel lymph nodes (non-SLNs) metastases in ILC and invasive ductal carcinoma (IDC). MATERIALS METHODS: Data relating to a total of 2583 patients with infiltrating breast carcinoma operated at our institution between 2012 and 2023 were retrospectively analyzed: 2242 (86...
April 17, 2024: World Journal of Surgical Oncology
https://read.qxmd.com/read/38627665/pan-inhibition-of-the-three-h-2-s-synthesizing-enzymes-restrains-tumor-progression-and-immunosuppression-in-breast-cancer
#36
JOURNAL ARTICLE
Alyaa Dawoud, Rana A Youness, Heba Nafea, Tamer Manie, Carole Bourquin, Csaba Szabo, Reham M Abdel-Kader, Mohamed Z Gad
BACKGROUND: Hydrogen sulfide (H2 S) is a significant endogenous mediator that has been implicated in the progression of various forms of cancer including breast cancer (BC). Cystathionine-β-synthase (CBS), cystathionine-γ-lyase (CSE), and 3-mercaptopyruvate sulfurtransferase (3MST) are the three principal mammalian enzymes responsible for H2 S production. Overexpression of CBS, CSE and 3MST was found to be associated with poor prognosis of BC patients. Moreover, H2 S was linked to an immune-suppressive tumor microenvironment in BC...
April 16, 2024: Cancer Cell International
https://read.qxmd.com/read/38627457/clinicopathological-characteristics-and-eligibility-for-adjuvant-olaparib-of-germline-brca1-2-mutation-carriers-with-her2-negative-early-breast-cancer
#37
JOURNAL ARTICLE
Stefania Morganti, Qingchun Jin, Julie Vincuilla, Ryan Buehler, Sean Ryan, Samantha Stokes, Tonia Parker, Elizabeth A Mittendorf, Tari A King, Anna Weiss, Ann H Partridge, Brittany L Bychkovsky, Giuseppe Curigliano, Nabihah Tayob, Nancy U Lin, Judy E Garber, Sara M Tolaney, Filipa Lynce
Following the survival benefit demonstrated in the OlympiA trial, one year of adjuvant olaparib is now recommended for all patients with germline BRCA1/2 pathogenic/likely pathogenic variants (PV) and high-risk, HER2-negative early breast cancer after chemotherapy. However, optimal identification of high-risk patients who may derive benefit from this genomically-directed therapy is debated. In this study, we sought to characterize the real-world proportion of gBRCA1/2 PV carriers eligible for adjuvant olaparib according to the OlympiA criteria, and to compare clinicopathologic characteristics and outcomes between eligible and ineligible patients...
April 16, 2024: NPJ Breast Cancer
https://read.qxmd.com/read/38627193/existing-psychiatric-diagnoses-among-breast-cancer-patients-interact-with-outcomes-after-autologous-and-implant-based-bilateral-breast-reconstruction-a-propensity-score-matched-analysis
#38
JOURNAL ARTICLE
George S Corpuz, Dylan K Kim, Isaac E Kim, Christine H Rohde
BACKGROUND: Breast reconstruction is an integral postoncologic procedure that has been associated with improved mental health and psychological outcomes. The possible interaction between existing psychiatric diagnoses hospital courses and postoperative complications warrants further exploration. METHODS: Bilateral breast reconstruction patients were identified from the 2016 to 2018 Healthcare Cost and Utilization Project-National Inpatient Sample (HCUP - NIS). Number and type of psychiatric diagnoses within the cohort were then evaluated using a host of ICD-10 codes...
March 24, 2024: Clinical Breast Cancer
https://read.qxmd.com/read/38626846/enhancing-breast-cancer-treatment-comprehensive-study-of-gefitinib-loaded-poloxamer-407-tpgs-mixed-micelles-through-design-development-in-silico-modelling-in-vitro-testing-and-ex-vivo-characterization
#39
JOURNAL ARTICLE
Padakanti Sandeep Chary, Ankush Bansode, Naveen Rajana, Valmala Bhavana, Siva Singothu, Anamika Sharma, Santosh Kumar Guru, Vasundhra Bhandari, Neelesh Kumar Mehra
Breast cancer continues to pose a substantial global health challenge, emphasizing the critical need for the advancement of novel therapeutic approaches. Key players in the regulation of apoptosis, a fundamental process in cell death, are the B-cell lymphoma 2 (Bcl-2) family proteins, namely Bcl-2 and Bax. These proteins have garnered attention as highly promising targets for the treatment of breast cancer. Targeting the overexpressed anti-apoptotic Bcl-2 protein in breast cancer, Gefitinib (GEF), an EGFR (Epidermal Growth Factor Receptor) inhibitor, emerges as a potential solution...
April 14, 2024: International Journal of Pharmaceutics
https://read.qxmd.com/read/38626719/disaggregating-the-asian-american-breast-cancer-population-disparities-in-reconstruction-rates
#40
JOURNAL ARTICLE
Claire M Eden, Leslie Kim, Laura Jao, Georgia Syrnioti, Josh Johnson, Anni Liu, Xi Kathy Zhou, Beth Siegel, Lisa A Newman, Manmeet Malik, Tammy Ju
INTRODUCTION: Breast cancer (BC) incidence has been increasing among Asian-Americans (AsAms); recent data suggest these patients are less likely to undergo postmastectomy breast reconstruction (PMBR) compared to non-Asian women. Historically, AsAm BC patients are reported in aggregate, masking heterogeneity within this population. We aim to identify patterns of postmastectomy reconstruction among disaggregated AsAm BC patients at our institution. METHODS: A retrospective chart review was performed for BC patients who underwent mastectomy between 2017 and 2021...
April 15, 2024: Journal of Surgical Research
keyword
keyword
17955
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.